Literature DB >> 19608689

Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia.

Kun Liu1, Maurizio Martini, Bianca Rocca, Christopher I Amos, Luciana Teofili, Fiorina Giona, Jianmin Ding, Hirokazu Komatsu, Luigi M Larocca, Radek C Skoda.   

Abstract

BACKGROUND: Hereditary thrombocythemia is a rare disease characterized by increased megakaryopoiesis and overproduction of platelets. Germ line mutations have been identified in the genes for thrombopoietin (THPO) and its receptor, MPL. A clustering of familial cases with the MPL-G1073A mutation that results in a serine to asparagine substitution (S505N) has been recently reported in Italy. Here we performed haplotype analysis in nine families (eight Italian and one Japanese) with hereditary thrombocythemia carrying the MPL-S505N mutation in the MPL gene. DESIGN AND METHODS: The MPL gene was examined by genomic DNA sequencing. Haplotype analysis was performed using microsatellites and single nucleotide polymorphisms.
RESULTS: Analysis of microsatellite markers and single nucleotide polymorphisms in the eight Italian families with hereditary thrombocythemia revealed the presence of a common haplotype compatible with a founder effect, which may have originated 23 generations ago. This haplotype was rarely observed in 132 unrelated individuals and was absent in a Japanese family with the MPL-S505N mutation.
CONCLUSIONS: The recurrent MPL-S505N mutation found in the eight Italian families with hereditary thrombocythemia is likely due to a founder effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608689      PMCID: PMC2754952          DOI: 10.3324/haematol.2009.005918

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  22 in total

Review 1.  Thrombopoietin.

Authors:  K Kaushansky
Journal:  N Engl J Med       Date:  1998-09-10       Impact factor: 91.245

2.  Activating mutations of the transmembrane domain of MPL in vitro and in vivo: incorrect sequence of MPL-K, an alternative spliced form of MPL.

Authors:  T Kitamura; M Onishi; T Yahata; Y Kanakura; S Asano
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

3.  Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene.

Authors:  N Ghilardi; A Wiestner; M Kikuchi; A Ohsaka; R C Skoda
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

4.  Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population.

Authors:  N Risch; D de Leon; L Ozelius; P Kramer; L Almasy; B Singer; S Fahn; X Breakefield; S Bressman
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

5.  An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia.

Authors:  A Wiestner; R J Schlemper; A P van der Maas; R C Skoda
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

6.  Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis.

Authors:  Alison R Moliterno; Donna M Williams; Laura I Gutierrez-Alamillo; Roberto Salvatori; Roxann G Ingersoll; Jerry L Spivak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-21       Impact factor: 11.205

7.  Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin.

Authors:  Jianmin Ding; Hirokazu Komatsu; Atsushi Wakita; Miyuki Kato-Uranishi; Masato Ito; Atsushi Satoh; Kazuya Tsuboi; Masakazu Nitta; Hiroshi Miyazaki; Shinsuke Iida; Ryuzo Ueda
Journal:  Blood       Date:  2004-02-05       Impact factor: 22.113

8.  Familial essential thrombocythemia associated with one-base deletion in the 5'-untranslated region of the thrombopoietin gene.

Authors:  T Kondo; M Okabe; M Sanada; M Kurosawa; S Suzuki; M Kobayashi; M Hosokawa; M Asaka
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

9.  Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene.

Authors:  El-Harith Abdelghaffar El-Harith; Cornelia Roesl; Matthias Ballmaier; Manuela Germeshausen; Hildegard Frye-Boukhriss; Nils von Neuhoff; Christian Becker; Gudrun Nürnberg; Peter Nürnberg; Mirghani Ali Mohamed Ahmed; Jeannette Hübener; Jörg Schmidtke; Karl Welte; Manfred Stuhrmann
Journal:  Br J Haematol       Date:  2008-11-19       Impact factor: 6.998

10.  The activating splice mutation in intron 3 of the thrombopoietin gene is not found in patients with non-familial essential thrombocythaemia.

Authors:  C N Harrison; R E Gale; A C Wiestner; R C Skoda; D C Linch
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

View more
  16 in total

1.  Clinical utility gene card for: hereditary thrombocythemia.

Authors:  Kais Hussein; Melanie Percy; Mary Frances McMullin; Jiří Schwarz; Susanne Schnittger; Naomi Porret; Luz Maria Martinez-Aviles; Beatriz Bellosillo Paricio; Stéphane Giraudier; Radek Skoda; Eric Lippert; Sylvie Hermouet; Holger Cario
Journal:  Eur J Hum Genet       Date:  2013-06-05       Impact factor: 4.246

2.  Hereditary myeloproliferative disorders.

Authors:  Radek C Skoda
Journal:  Haematologica       Date:  2010-01       Impact factor: 9.941

Review 3.  Mouse models of diseases of megakaryocyte and platelet homeostasis.

Authors:  Catherine L Carmichael; Warren S Alexander
Journal:  Mamm Genome       Date:  2011-06-11       Impact factor: 2.957

4.  The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm.

Authors:  Veena Sangkhae; S Leah Etheridge; Kenneth Kaushansky; Ian S Hitchcock
Journal:  Blood       Date:  2014-10-22       Impact factor: 22.113

5.  Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms.

Authors:  Daniela Pietra; Angela Brisci; Elisa Rumi; Sabrina Boggi; Chiara Elena; Alessandro Pietrelli; Roberta Bordoni; Maurizio Ferrari; Francesco Passamonti; Gianluca De Bellis; Laura Cremonesi; Mario Cazzola
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

6.  Expanding the Spectrum of Founder Mutations Causing Isolated Gonadotropin-Releasing Hormone Deficiency.

Authors:  Jin-Ho Choi; Ravikumar Balasubramanian; Phil H Lee; Natalie D Shaw; Janet E Hall; Lacey Plummer; Cassandra L Buck; Marie-Laure Kottler; Katarzyna Jarzabek; Sławomir Wołczynski; Richard Quinton; Ana Claudia Latronico; Catherine Dode; Tsutomu Ogata; Hyung-Goo Kim; Lawrence C Layman; James F Gusella; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2015-07-24       Impact factor: 5.958

7.  Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis.

Authors:  Luciana Teofili; Fiorina Giona; Lorenza Torti; Tonia Cenci; Bianca Maria Ricerca; Carlo Rumi; Vittorio Nunes; Robin Foà; Giuseppe Leone; Maurizio Martini; Luigi Maria Larocca
Journal:  Haematologica       Date:  2009-08-27       Impact factor: 9.941

Review 8.  Back to biology: new insights on inheritance in myeloproliferative disorders.

Authors:  Evan M Braunstein; Alison R Moliterno
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

9.  An Asian-specific MPL genetic variant alters JAK-STAT signaling and influences platelet count in the population.

Authors:  Pengfei Sun; Wei Zhou; Yi Fu; Chloe Y Y Cheung; Yujun Dong; Min-Lee Yang; He Zhang; Jia Jia; Yong Huo; Cristen J Willer; Y Eugene Chen; Clara S Tang; Hung-Fat Tse; Karen S L Lam; Wei Gao; Ming Xu; Haiyi Yu; Pak Chung Sham; Yan Zhang; Santhi K Ganesh
Journal:  Hum Mol Genet       Date:  2021-05-28       Impact factor: 6.150

Review 10.  Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases.

Authors:  Xin He; Zhigang Chen; Yangyan Jiang; Xi Qiu; Xiaoying Zhao
Journal:  J Hematol Oncol       Date:  2013-01-25       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.